Lv737
4896 积分 2021-02-11 加入
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment
2天前
已完结
Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial
2天前
已完结
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
2天前
已完结
Discovery of Potent and Selective BCL6 Ligand-Directed Degrader (LDD), BCL6-760
3天前
已完结
Targeting GDF-15 in cancer cachexia and immunity
4天前
已完结
Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2
15天前
已完结
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
2个月前
已完结
Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells
2个月前
已完结
Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidence
2个月前
已完结
Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy
2个月前
已完结